ClinicalTrials.Veeva

Menu
C

Creighton University | Clinical Research Office

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 1015550
Nintedanib
Calcium
Risperidone
Olanzapine
Teriparatide
Chlorthalidone
Rasagiline
Carbidopa
Bexotegrast

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 107 total trials

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Enrolling
Refractory Chronic Cough
Drug: Placebo
Drug: BLU-5937

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have c...

Enrolling
Progressive Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Drug: BI 1015550

This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic...

Active, not recruiting
Lung Diseases, Interstitial
Drug: BI 1015550
Drug: Placebo

A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of bexotegrast (PLN-74809) for the treatment o...

Enrolling
Idiopathic Pulmonary Fibrosis
Drug: PLN-74809
Drug: Placebo

Trial sponsors

C
Boehringer Ingelheim logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
Abbott logo
Columbia University logo
Exact Sciences Corporation logo
Pfizer logo
Teva Pharmaceuticals logo
E
Abbott logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems